Plasma Therapy Global Market To Reach Value Of $320 Million In 2025
8 Dec, 2021
Global Plasma Therapy Market Size And Drivers:
The global plasma therapy market is expected to grow from $230 million in 2020 to $250 million in 2021 at a compound annual growth rate (CAGR) of 8.7%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The plasma therapy market is expected to reach $320 million in 2025 at a CAGR of 6%. The rising prevalence of osteoarthritis is expected to drive the plasma therapy market during the forecast period.
Request For A Sample For The Global Plasma Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp
Trends In The Global Plasma Therapy Market
Convalescent plasma therapy, to treat patients suffering from COVID-19 is a leading trend in the plasma therapy market. Convalescent plasma is the plasma extracted from the individuals who have been cured of a particular viral infection, as they have antibodies that protect and make them immune to that particular organism. The convalescent plasma is transfused to the patient who is suffering from the viral infection to neutralize the viral infection and induce the active immune response to cure the infection. Convalescent plasma therapy is found to be a safe treatment to cure the patients infected with the coronavirus. Moreover, this therapy was used to treat other viral infections such as Ebola, Dengue, and SARS- 1 but did not give the desired result. In March 2020, Takeda Pharmaceutical Company Limited has initiated a plasma-therapy, Anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG), which is termed as TAK-888 for treating COVID-19. The TAK-888 utilizes the plasma collected from convalescent donors who have been cured of COVID-19 and is administered to the patient suffering from COVID-19.
Global Plasma Therapy Market Segments:
The global plasma therapy market is further segmented –
By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Others
By End-Users: Hospitals & Clinics, Laboratories, Research Institutes
By Geography: The global plasma therapy market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Plasma Therapy Market At:
https://www.thebusinessresearchcompany.com/report/plasma-therapy-global-market-report-2020-30-covid-19-growth-and-changePlasma Therapy Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides plasma therapy market overviews, analyzes and forecasts market size and growth for the global plasma therapy market, plasma therapy market share, plasma therapy market players, plasma therapy market segments and geographies, plasma therapy market’s leading competitors’ revenues, profiles and market shares. The plasma therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.